Exagen Inc. XGN Number of Exercisable Options
Number of Exercisable Options at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s number of exercisable options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s number of exercisable options?
- Exagen Inc. (XGN) reported number of exercisable options of $179K in Q1 2026.
- How has Exagen Inc.'s number of exercisable options changed year-over-year?
- Exagen Inc.'s number of exercisable options decreased by 30.1% year-over-year, from $256K to $179K.
- What is the long-term trend for Exagen Inc.'s number of exercisable options?
- Over 5 years (2020 to 2025), Exagen Inc.'s number of exercisable options has grown at a -28.8% compound annual growth rate (CAGR), from $3.36M to $617K.
- What does number of exercisable options mean?
- The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.